Andere talen Thiogenesis Therapeutics, Corp.

Aandelen

TTI

CA88410L1022

Beurs gesloten - Toronto S.E. Andere beurzen 20:37:58 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7 ^CAD	-1,41%		0,00%	-6,67%

24/05	Thiogenesis Therapeutics, Corp. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
29/04	Thiogenesis Therapeutics, Corp. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Thiogenesis Therapeutics, Corp. Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS	25/03
Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS	25/03
Thiogenesis Announces Closing of Final Tranche in $4.5 Million Non-Brokered Private Placement	20/12
Thiogenesis Therapeutics, Corp. announced that it has received CAD 4.500875 million in funding	20/12
Thiogenesis Therapeutics Completes Non-Brokered Private Placement	18/12
Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation	18/12
Thiogenesis Therapeutics, Corp. announces tranche update	18/12
Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium	04/12
Thiogenesis Therapeutics, Corp. Announces Appointment of Vincent Stanton Jr. to the Scientific Advisory Board	27/11
Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board	27/11
Thiogenesis Announces Non-Brokered Private Placement of Common Shares	20/11
Thiogenesis Therapeutics, Corp. announced that it expects to receive CAD 4.5 million in funding	20/11
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24-08-23
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	24-05-23
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	29-04-23
Thiogenesis Therapeutics Completes Oversubscribed $5.3 Million Non-Brokered Private Placement	21-11-22
Thiogenesis Therapeutics, Corp. announced that it has received CAD 5.3097 million in funding	21-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Thiogenesis Therapeutics, Corp.

Aandelen

TTI

CA88410L1022

Andere talen

Filters